imuldosa - ustekinumab - srlf injection
(Ustekinumab-Srlf)Golden State Medical Supply, Inc.
Interleukin-23 Antagonist [EPC] class drugs
11 results
imuldosa - ustekinumab - srlf injection
(Ustekinumab-Srlf)Accord Biopharma Inc.otulfi - ustekinumab - aauz injection, solution
(Ustekinumab-Aauz)Fresenius Kabi Usa, Llcpyzchiva - ustekinumab - ttwe injection, solution
(Ustekinumab-Ttwe)Cordavis Limitedpyzchiva - ustekinumab - ttwe injection, solution
(Ustekinumab-Ttwe)Sandoz Incskyrizi - risankizumab - rzaa
(Risankizumab-Rzaa)Abbvie Inc.stelara - ustekinumab injection, solution
(Ustekinumab)Janssen Biotech, Inc.Usage: STELARA is indicated for treating moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active ulcerative colitis in adults. It is also approved for moderate to severe plaque psoriasis and psoriatic arthritis in pediatric patients aged 6 and older.tremfya - guselkumab injection
(Guselkumab)Janssen Biotech, Inc.ustekinumab - ustekinumab injection, solution
(Ustekinumab)Janssen Biotech, Inc.Usage: Ustekinumab is indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active ulcerative colitis in adults. It is also approved for pediatric patients aged 6 and older with moderate to severe plaque psoriasis and active psoriatic arthritis.ustekinumab-aauz
(Ustekinumab-Aauz)Fresenius Kabi Usa, Llc